# Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/drugs-targeting-cd20-in-multiple-sclerosis-pharmacology-efficacy-safety-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Alise Carlson,Moein Amin,Jeffrey A. Cohen |
| Citations | 73 |
| DOI | 10.1007/s40265-024-02011-w |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s40265-024-02011-w.pdf |
| OpenAlex ID | https://openalex.org/W4392816538 |
| PMID | 38480630 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Alise Carlson](https://scholariq.org/researchers/alise-carlson/)

## Paper journal

- [Drugs](https://scholariq.org/journals/drugs/)

## Paper primary topic

- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)

## Paper topics

- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.